Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 600

1.

Mood stabilization and destabilization during acute and continuation phase treatment for bipolar I disorder with lamotrigine or placebo.

Goldberg JF, Calabrese JR, Saville BR, Frye MA, Ketter TA, Suppes T, Post RM, Goodwin FK.

J Clin Psychiatry. 2009 Sep;70(9):1273-80. doi: 10.4088/JCP.08m04381. Epub 2009 Aug 11.

PMID:
19689918
2.

A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder.

Bowden CL, Calabrese JR, Sachs G, Yatham LN, Asghar SA, Hompland M, Montgomery P, Earl N, Smoot TM, DeVeaugh-Geiss J; Lamictal 606 Study Group..

Arch Gen Psychiatry. 2003 Apr;60(4):392-400. Erratum in: Arch Gen Psychiatry. 2004 Jul;61(7):680.

PMID:
12695317
3.

A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder.

Calabrese JR, Bowden CL, Sachs G, Yatham LN, Behnke K, Mehtonen OP, Montgomery P, Ascher J, Paska W, Earl N, DeVeaugh-Geiss J; Lamictal 605 Study Group..

J Clin Psychiatry. 2003 Sep;64(9):1013-24.

PMID:
14628976
4.

A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group.

Calabrese JR, Bowden CL, Sachs GS, Ascher JA, Monaghan E, Rudd GD.

J Clin Psychiatry. 1999 Feb;60(2):79-88.

PMID:
10084633
5.

A 52-week, open-label continuation study of lamotrigine in the treatment of bipolar depression.

McElroy SL, Zarate CA, Cookson J, Suppes T, Huffman RF, Greene P, Ascher J.

J Clin Psychiatry. 2004 Feb;65(2):204-10.

PMID:
15003074
6.

Efficacy and safety of lamotrigine as add-on treatment to lithium in bipolar depression: a multicenter, double-blind, placebo-controlled trial.

van der Loos ML, Mulder PG, Hartong EG, Blom MB, Vergouwen AC, de Keyzer HJ, Notten PJ, Luteijn ML, Timmermans MA, Vieta E, Nolen WA; LamLit Study Group..

J Clin Psychiatry. 2009 Feb;70(2):223-31. Epub 2008 Dec 30.

PMID:
19200421
7.

A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder.

Goodwin GM, Bowden CL, Calabrese JR, Grunze H, Kasper S, White R, Greene P, Leadbetter R.

J Clin Psychiatry. 2004 Mar;65(3):432-41.

PMID:
15096085
8.

A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder. Lamictal 614 Study Group.

Calabrese JR, Suppes T, Bowden CL, Sachs GS, Swann AC, McElroy SL, Kusumakar V, Ascher JA, Earl NL, Greene PL, Monaghan ET.

J Clin Psychiatry. 2000 Nov;61(11):841-50.

PMID:
11105737
9.

Effect of lamotrigine on cognitive complaints in patients with bipolar I disorder.

Khan A, Ginsberg LD, Asnis GM, Goodwin FK, Davis KH, Krishnan AA, Adams BE.

J Clin Psychiatry. 2004 Nov;65(11):1483-90.

PMID:
15554760
10.

ECNP consensus meeting. Bipolar depression. Nice, March 2007.

Goodwin GM, Anderson I, Arango C, Bowden CL, Henry C, Mitchell PB, Nolen WA, Vieta E, Wittchen HU.

Eur Neuropsychopharmacol. 2008 Jul;18(7):535-49. doi: 10.1016/j.euroneuro.2008.03.003. Epub 2008 May 23. Review.

PMID:
18501566
11.

Long-term treatment of bipolar disorder with lamotrigine.

Calabrese JR, Shelton MD, Rapport DJ, Kimmel SE, Elhaj O.

J Clin Psychiatry. 2002;63 Suppl 10:18-22. Review.

12.

The efficacy of lamotrigine in rapid cycling and non-rapid cycling patients with bipolar disorder.

Bowden CL, Calabrese JR, McElroy SL, Rhodes LJ, Keck PE Jr, Cookson J, Anderson J, Bolden-Watson C, Ascher J, Monaghan E, Zhou J.

Biol Psychiatry. 1999 Apr 15;45(8):953-8.

PMID:
10386176
13.

Lamotrigine: a review of its use in bipolar disorder.

Goldsmith DR, Wagstaff AJ, Ibbotson T, Perry CM.

Drugs. 2003;63(19):2029-50. Review.

PMID:
12962521
14.

Spectrum of activity of lamotrigine in treatment-refractory bipolar disorder.

Calabrese JR, Bowden CL, McElroy SL, Cookson J, Andersen J, Keck PE Jr, Rhodes L, Bolden-Watson C, Zhou J, Ascher JA.

Am J Psychiatry. 1999 Jul;156(7):1019-23.

PMID:
10401445
15.

A 7-week, randomized, double-blind trial of olanzapine/fluoxetine combination versus lamotrigine in the treatment of bipolar I depression.

Brown EB, McElroy SL, Keck PE Jr, Deldar A, Adams DH, Tohen M, Williamson DJ.

J Clin Psychiatry. 2006 Jul;67(7):1025-33.

PMID:
16889444
16.

Is anticonvulsant treatment of mania a class effect? Data from randomized clinical trials.

Rosa AR, Fountoulakis K, Siamouli M, Gonda X, Vieta E.

CNS Neurosci Ther. 2011 Jun;17(3):167-77. doi: 10.1111/j.1755-5949.2009.00089.x. Epub 2009 Dec 15. Review.

PMID:
20015083
17.
18.

A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group.

Bowden CL, Calabrese JR, McElroy SL, Gyulai L, Wassef A, Petty F, Pope HG Jr, Chou JC, Keck PE Jr, Rhodes LJ, Swann AC, Hirschfeld RM, Wozniak PJ.

Arch Gen Psychiatry. 2000 May;57(5):481-9.

PMID:
10807488
19.

Clinical studies on the use of lamotrigine in bipolar disorder.

Calabrese JR, Rapport DJ, Shelton MD, Kujawa M, Kimmel SE.

Neuropsychobiology. 1998 Oct;38(3):185-91. Review.

PMID:
9778607
20.

Supplemental Content

Support Center